Clinical trial
Cross-sectional, Multicentric, Non-interventional Study to Assess the Frequency and the Management of Cachexia and Associated Symptoms in Patients With Non-small Cell Lung Cancer.
NCT02968979 is registered in ClinicalTrials.gov with Chugai Pharma France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross-sectional, Multicentric, Non-interventional Study to Assess the Frequency and the Management of Cachexia and Associated Symptoms in Patients With Non-small Cell Lung Cancer.
- Lead sponsor
- Chugai Pharma France
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- October 31, 2016
- Enrollment
- 539 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cachexia, non-small cell lung cancer